In Vivo Detection of Small Subsurface Melanomas in Athymic Mice Using Noninvasive Fiber Optic Confocal Imaging  Peter Anikijenko, Liem T. Vo, Elise R.

Slides:



Advertisements
Similar presentations
Mihaela Skobe, Michael Detmar 
Advertisements

Mihaela Skobe, Michael Detmar 
Colocalization of Glial Fibrillary Acidic Protein, Metallothionein, and MHC II in Human, Rat, NOD/SCID, and Nude Mouse Skin Keratinocytes and Fibroblasts 
Fibroblast Activation Protein: Differential Expression and Serine Protease Activity in Reactive Stromal Fibroblasts of Melanocytic Skin Tumors  Margit.
Inhibition of Platelet GPIbα and Promotion of Melanoma Metastasis
Dual Mode Reflectance and Fluorescence Confocal Laser Scanning Microscopy for In Vivo Imaging Melanoma Progression in Murine Skin  Yanyun Li, Salvador.
Peroxiredoxin is Ubiquitously Expressed in Rat Skin: Isotype-Specific Expression in the Epidermis and Hair Follicle  Jeong Eun Lee, Byung Dae Kwon, Jee-Bum.
BM-40(Osteonectin, SPARC) Is Expressed Both in the Epidermal and in the Dermal Compartment of Adult Human Skin  Nicholas Hunzelmann, Martin Hafner, Sabine.
Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions  Riichiro Abe, Tadamichi Shimizu, Hiroshi Sugawara, Hirokazu Watanabe,
Basement Membrane Zone Remodeling During Appendageal Development in Human Fetal Skin. The Absence of Type VII Collagen is Associated with Gelatinase-A.
Enrichment for Living Murine Keratinocytes from the Hair Follicle Bulge with the Cell Surface Marker CD34  Rebecca J. Morris, Carl D. Bortner, George.
Loss of EPC-1/PEDF Expression During Skin Aging In Vivo
GW Bodies: Cytoplasmic Compartments in Normal Human Skin
Applications of Nanotechnology in Dermatology
Establishment of Murine Basal Cell Carcinoma Allografts: A Potential Model for Preclinical Drug Testing and for Molecular Analysis  Grace Ying Wang, Po-Lin.
Epidermal Label-Retaining Cells: Background and Recent Applications
Woo Chi, Odysseas Morgan, Eleanor Wu, Bruce A. Morgan 
Label-Retaining Cells (Presumptive Stem Cells) of Mice Vibrissae Do Not Express Gap Junction Protein Connexin 43  Maja Matic, Marcia Simon  Journal of.
Mitsutoshi Tominaga, Hideoki Ogawa, Kenji Takamori 
Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor Activation of Keratinocyte ErbB Receptors Mediates Epidermal Hyperplasia, a Prominent Side-Effect.
Transcription Factor CTIP2 Maintains Hair Follicle Stem Cell Pool and Contributes to Altered Expression of LHX2 and NFATC1  Shreya Bhattacharya, Heather.
Toshiyuki Yamamoto, Kiyoshi Nishioka 
Light and Electron Microscopic Demonstration of the p75 Nerve Growth Factor Receptor in Normal Human Cutaneous Nerve Fibers: New Vistas  Yong Liang, Olle.
Evidence that Anti-Type VII Collagen Antibodies Are Pathogenic and Responsible for the Clinical, Histological, and Immunological Features of Epidermolysis.
Circulating Tumor Cells and Melanoma Progression
Alexandra Charruyer, Lauren R. Strachan, Lili Yue, Alexandra S
Matthew A. Sleeman, James D. Watson, J. Greg Murison 
Presence of Epstein–Barr Virus in Langerhans Cells of CTCL Lesions
Live Confocal Microscopy of Oligonucleotide Uptake by Keratinocytes in Human Skin Grafts on Nude Mice  Paul J. White, Rhys D. Fogarty, Ingrid J. Liepe,
Hair Follicles Guide Nerve Migration In Vitro and In Vivo in Tissue-Engineered Skin  Vicky Gagnon, Danielle Larouche, Rémi Parenteau-Bareil, Marie Gingras,
A Simple In Vivo System for Studying Epithelialization, Hair Follicle Formation, and Invasion Using Primary Epidermal Cells from Wild-Type and Transgenic.
Supranuclear Melanin Caps Reduce Ultraviolet Induced DNA Photoproducts in Human Epidermis  Nobuhiko Kobayashi, Akemi Nakagawa, Tsutomu Muramatsu, Yukio.
Expression of T-Cadherin in Basal Keratinocytes of Skin
Epithelial Cells in the Hair Follicle Bulge do not Contribute to Epidermal Regeneration after Glucocorticoid-Induced Cutaneous Atrophy  Dmitry V. Chebotaev,
Epidermal Stem Cells do not Communicate Through Gap Junctions
CD4+ CD56+ Blastic Tumor Cells Express CD101 Molecules
Minutes of the Board of Directors Meeting
Trangenic Misexpression of the Differentiation-Specific Desmocollin Isoform 1 in Basal Keratinocytes  Frank Henkler, Molly Strom, Kathleen Mathers, Hayley.
Superantigens, Autoantigens, and Pathogenic T Cells in Psoriasis
Murine Epidermal Label-Retaining Cells Isolated by Flow Cytometry do not Express the Stem Cell Markers CD34, Sca-1, or Flk-1  Michael R. Albert, Ruth-Ann.
Matthew C. Pickering, Susanne Fischer, Margarita R. Lewis, Mark J
Protease-Activated Receptor 2, a Receptor Involved in Melanosome Transfer, is Upregulated in Human Skin by Ultraviolet Irradiation  Glynis Scott, Cristina.
Misbah Huzaira, Francisca Rius, Milind Rajadhyaksha, R
Keratinocytes Express the CD146 (Muc18/S-Endo) Antigen in Tissue Culture and During Inflammatory Skin Diseases1  Wolfgang Weninger, Michael Rendl, Michael.
Journal of Investigative Dermatology 
CXCR4 in Epidermal Keratinocytes: Crosstalk within the Skin
Yoshiharu Kawaguchi  Journal of Investigative Dermatology 
Intranuclear Localization of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) During Cell Division in Human Keratinocytes  Christopher J. Wraight,
Role of Cytotoxic T Cells in Chronic Alopecia Areata
Flotillas of Lipid Rafts in Transit Amplifying Cell-Like Keratinocytes
Society for Investigative Dermatology 2010 Meeting Minutes
Multiple Epidermal Connexins are Expressed in Different Keratinocyte Subpopulations Including Connexin 31  Wei-Li Di, Elizabeth L. Rugg, Irene M. Leigh,
Detection of a Physiological Juvenile Phase and the Central Role of Pericytes in Human Dermal Microvascular Aging  Peter Helmbold, Christine Lautenschläger,
Research Snippets Journal of Investigative Dermatology
Intravital Multiphoton Imaging of Cutaneous Immune Responses
The Creatine Kinase System in Human Skin: Protective Effects of Creatine Against Oxidative and UV Damage In Vitro and In Vivo  Holger Lenz, Melanie Schmidt,
Urokinase is a Positive Regulator of Epidermal Proliferation In Vivo
Research Snippets from the British Journal of Dermatology
Persistent Transgene Expression and Normal Differentiation of Immortalized Human Keratinocytes In Vivo  Gerald G. Krueger, Cynthia M. Jorgensen, Andrew.
Keratinocyte Differentiation in Hyperproliferative Epidermis: Topical Application of PPARα Activators Restores Tissue Homeostasis  László G. Kömüves,
John P. Sundberg, Lloyd E. King 
Yasushi Hanakawa, Hong Li, Chenyan Lin, John R
Lack of Membrane Expression of Interleukin-2 Receptor α Chain (CD25) in Mycosis Fungoides: Application of Laser Scanning Cytometry for Phenotyping of.
Liren Tang, Shabnam Madani, Harvey Lui, Jerry Shapiro 
Y. Albert Pan, Joshua R. Sanes  Journal of Investigative Dermatology 
Errata Journal of Investigative Dermatology
Yoshinori Aragane, Akira Maeda, Chang-Yi Cui, Tadashi Tezuka 
Human Melanocytes and Keratinocytes Exposed to UVB or UVA In Vivo Show Comparable Levels of Thymine Dimers  Antony R. Young  Journal of Investigative.
Flotillas of Lipid Rafts in Transit Amplifying Cell-Like Keratinocytes
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

In Vivo Detection of Small Subsurface Melanomas in Athymic Mice Using Noninvasive Fiber Optic Confocal Imaging  Peter Anikijenko, Liem T. Vo, Elise R. Murr, Jennifer Carrasco, Wendy J. McLaren, Roger G. King  Journal of Investigative Dermatology  Volume 117, Issue 6, Pages 1442-1448 (December 2001) DOI: 10.1046/j.0022-202x.2001.01592.x Copyright © 2001 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 FOCI of living melanoma cells in vitro. Plasma membrane labeling following incubation with (a) CD51/61-FITC 1:5 dilution; HY cells; (b) 14.G2a-FITC (1:5 dilution; NMD cells); (c) 9.2.27-FITC (1:5 dilution; NMD cells). In the absence of antibody, normal human keratinocytes (d) and MW melanoma cells (e) showed little or no fluorescence. Scale bars: (a, c–e) 60 µm; (b) 45 µm. Journal of Investigative Dermatology 2001 117, 1442-1448DOI: (10.1046/j.0022-202x.2001.01592.x) Copyright © 2001 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Subsurface confocal images of implanted melanoma tumors in athymic mice in vivo, after administration of 0.2 ml of 1:5 diluted antimelanoma antibodies. (a) MW melanoma tumor site in an athymic mouse before administration of the antibodies. (b) Normal mouse skin image following CD51/61-FITC administration intravenously into an athymic mouse with no implanted tumor. (c) NMD melanoma after CD51/61-FITC administration. (d) NMD melanoma following administration of 9.2.27-FITC. (e) NMD melanoma tumor following administration of 14.G2a-FITC. (f) Implanted normal human skin cells in an athymic mouse after the administration of CD51/61-FITC showing little or no fluorescence. (g) NMD melanoma tumor following administration of FITC-conjugated mouse IgG1, κ monoclonal Ig isotype control showing little, scattered fluorescence. (h) NMD melanoma tumor after the administration of FITC-conjugated mouse IgG1, κ monoclonal Ig isotype control followed by the administration of CD52/61-FITC. (i) MW melanoma tumor following administration of FITC-conjugated mouse IgG1, κ monoclonal Ig isotype control showing little, scattered fluorescence. (j) MW melanoma tumor after the administration of FITC-conjugated mouse IgG1, κ monoclonal Ig isotype control followed by the administration of CD52/61-FITC. (k) HY melanoma tumor following administration of FITC-conjugated mouse IgG1, κ monoclonal Ig isotype control. (l) HY melanoma tumor after the administration of FITC-conjugated mouse IgG1, κ monoclonal Ig isotype control followed by the administration of CD52/61-FITC. Scale bars: (a, b, g, k) 30 µm; (c) 60 µm; (d, l) 50 µm; (e, f, h–j) 75 µm. Journal of Investigative Dermatology 2001 117, 1442-1448DOI: (10.1046/j.0022-202x.2001.01592.x) Copyright © 2001 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 FOCI of excised melanoma tumor sites from the dermal surface. (a) NMD melanoma imaged from the dermal surface after epidermal in vivo imaging, intravenous administration of CD51/61-FITC (0.2 ml, 1:5 dilution). (b) Imaged from the dermal surface NMD melanoma tumor after in vivo intravenous administration of 14.G2a-FITC (0.2 ml, 1:5 dilution). (c) HY melanoma imaged from the dermal surface after in vivo intravenous administration of 9.2.27-FITC (0.2 ml, 1:5 dilution). (d) MW melanoma imaged from the dermal surface with no fluorescent antibody administered, showing no fluorescence. Scale bars: (a, c, d) 45 µm; (b) 75 µm. Journal of Investigative Dermatology 2001 117, 1442-1448DOI: (10.1046/j.0022-202x.2001.01592.x) Copyright © 2001 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Conventional immunoperoxidase-stained cross-section of mouse skin. (a) S100-stained melanoma cells (→) below the epidermis (Epi). Hair follicles (HF), collagen fibers (C). Nerves cells (N) are also positively stained. (b) Negative control (no S100) of cross-section through athymic mouse skin showing no positively stained cells below the epidermis (Epi). Scale bars: (a, b) 30 µm. Journal of Investigative Dermatology 2001 117, 1442-1448DOI: (10.1046/j.0022-202x.2001.01592.x) Copyright © 2001 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Changes in melanoma-associated vasculature as imaged by FOCI, in vivo. (a) Confocal image of normal murine dermal vasculature following intravenous administration of FITC-dextran (0.3 ml, 10 mg per ml) in an athymic mouse without a melanoma implant. (b) FOCI image of the dermal vasculature in and around an implanted melanoma tumor of an athymic mouse, following intravenous administration of (0.3 ml, 10 mg per ml) FITC-dextran. (c) Dual channel confocal image showing melanoma-associated dermal microvasculature labeled red (Texas Red-dextran; 0.2 ml, 10 mg per ml, intravenous) and the green labeled melanoma tumor (CD51/61-FITC; 0.2 ml, 1:5 dilution, intravenous). Scale bars: (a) 200 µm; (b) 250 µm; (c) 150 µm. Journal of Investigative Dermatology 2001 117, 1442-1448DOI: (10.1046/j.0022-202x.2001.01592.x) Copyright © 2001 The Society for Investigative Dermatology, Inc Terms and Conditions